Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
GlobeNewswire · 财报与经营业绩 · November 5, 2026 at 4:17 PM ET
Read the full report at the original publisher.